Characterization of a novel oncogenic K-ras mutation in colon cancer
Journal Article
·
· Biochemical and Biophysical Research Communications
- Molecular Diagnosis and Cancer Prevention Division, Saitama Cancer Center, 818 Komuro Ina, Kitaadachigun, Saitama 362-0806 (Japan) and Research Institute for Clinical Oncology, Saitama Cancer Center, 818 Komuro Ina, Kitaadachigun, Saitama 362-0806 (Japan)
- Molecular Diagnosis and Cancer Prevention Division, Saitama Cancer Center, 818 Komuro Ina, Kitaadachigun, Saitama 362-0806 (Japan)
- Gastroenterology Division, Saitama Cancer Center, 818 Komuro Ina, Kitaadachigun, Saitama 362-0806 (Japan)
- Research Institute for Clinical Oncology, Saitama Cancer Center, 818 Komuro Ina, Kitaadachigun, Saitama 362-0806 (Japan)
Activating mutations of RAS are frequently observed in subsets of human cancers, indicating that RAS activation is involved in tumorigenesis. Here, we identified and characterized a novel G to T transversion mutation of the K-ras gene at the third position of codon 19 (TTG) which substituted phenylalanine for leucine in 3 primary colon carcinomas. Biological and biochemical activity was examined using transformed NIH3T3 cells expressing mutant or wild-type K-ras. Transformants harboring the K-ras mutation at codon 19 showed proliferative capacity under serum-starved conditions, less contact inhibition, anchorage-independent growth, tumorigenicity in nude mice and elevation of active Ras-GTP levels. These results indicated that this novel mutation possesses high oncogenic activity.
- OSTI ID:
- 20857968
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 3 Vol. 352; ISSN BBRCA9; ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma
Liver tumors induced in B6C3F{sub 1} mice by benz[a]anthracene and two of its halogenated derivatives contain K-RAS oncogene mutations
Anti-tumor activity of ESX1 on cancer cells harboring oncogenic K-ras mutation
Patent
·
Mon Feb 15 23:00:00 EST 1988
·
OSTI ID:5111711
Liver tumors induced in B6C3F{sub 1} mice by benz[a]anthracene and two of its halogenated derivatives contain K-RAS oncogene mutations
Journal Article
·
Wed Oct 01 00:00:00 EDT 1997
· Environmental and Molecular Mutagenesis
·
OSTI ID:530876
Anti-tumor activity of ESX1 on cancer cells harboring oncogenic K-ras mutation
Journal Article
·
Fri May 23 00:00:00 EDT 2008
· Biochemical and Biophysical Research Communications
·
OSTI ID:21143699